Tower Research Capital LLC TRC grew its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 138.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 215,092 shares of the medical equipment provider’s stock after acquiring an additional 125,056 shares during the quarter. […]
Tower Research Capital LLC TRC grew its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 138.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 215,092 shares of the medical equipment provider’s stock after acquiring an additional 125,056 shares during the quarter. […]
Rhenman & Partners Asset Management AB boosted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 7.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 750,000 shares of the medical equipment provider’s stock after purchasing an additional 50,000 shares during the period. Boston Scientific accounts for 4.3% of Rhenman & Partners Asset […]
Boston Scientific Co. (NYSE:BSX – Get Free Report) EVP Arthur C. Butcher sold 14,011 shares of the stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $75.34, for a total transaction of $1,055,588.74. Following the transaction, the executive vice president now owns 20,197 shares in the company, […]
Parnassus Investments LLC raised its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 26.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,711 shares of the medical equipment provider’s stock after acquiring an additional 2,038 shares during the quarter. Parnassus […]